Oral Ivermectin Dosing for Head Lice in an 80kg Female
For an 80kg female with head lice, administer oral ivermectin 400 mcg/kg (32 mg total, approximately 11 tablets of 3mg each), repeated in 7 days.
Dosing Rationale
The evidence clearly supports the higher 400 mcg/kg regimen over the traditional 200 mcg/kg dose. According to American Academy of Pediatrics guidelines, a single oral dose of 400 mcg/kg repeated in 7 days has been shown to be more effective than 0.5% malathion lotion 1. This higher dose regimen demonstrates superior efficacy compared to the older 200 mcg/kg dosing repeated at 10 days 1.
Specific Calculation for 80kg Patient:
- Dose per administration: 400 mcg/kg × 80 kg = 32,000 mcg (32 mg)
- Number of 3mg tablets: Approximately 11 tablets per dose
- Timing: Repeat the same dose 7 days after the first administration
Important Safety Considerations
Weight Requirement
This patient at 80kg is well above the minimum safety threshold. Ivermectin should not be used in patients weighing less than 15 kg due to potential blood-brain barrier penetration and neural transmission blockade 1. Your patient is safe to receive this medication.
Administration Instructions
- Take tablets on an empty stomach with water 2
- This maximizes absorption and efficacy
- Note: Taking with a high-fat meal increases bioavailability 2.5-fold, but fasting administration is the standard recommendation 2
Expected Outcomes
Based on clinical trial data:
- First dose efficacy: Approximately 77% complete cure rate after single dose 3
- After second dose: Cure rates increase to 92-95% 4
- Adult lice eradication: 100% after first dose, but viable nits may persist requiring the second dose 5
The 7-day interval for the second dose is critical because it targets newly hatched lice from any surviving nits before they reach reproductive maturity.
Critical Caveats
FDA Approval Status
Neither oral nor topical ivermectin is currently FDA-approved as a pediculicide 1. However, the FDA-approved dosing for strongyloidiasis is 200 mcg/kg 2, which is lower than the recommended 400 mcg/kg for lice. This represents off-label use at a higher dose.
Resistance Concerns
Emerging ivermectin resistance has been documented, with treatment failure rates of approximately 7.5% in some populations 3. If treatment fails after two properly administered doses, consider alternative therapies.
Why Two Doses Are Necessary
Ivermectin has limited ovicidal activity - it kills adult lice and larvae but not all eggs 1. The second dose at day 7 eliminates any lice that hatched from surviving nits after the first treatment, preventing reinfestation.
Monitoring
- Day 8 assessment: Check for presence of live lice or viable nits
- Day 15 (after second dose): Verify complete eradication
- Day 29: Confirm no reinfestation has occurred 4
Signs of Treatment Success:
- Complete resolution of excoriations
- Minimal or no pruritus (93% of patients) 5
- No viable nits or adult lice on examination
Alternative Considerations
If this represents treatment failure from topical agents, oral ivermectin is particularly appropriate. The evidence shows oral ivermectin at 400 mcg/kg is superior to topical malathion 1, making it an excellent choice for resistant cases or when compliance with topical treatments is problematic.